Live Breaking News & Updates on Director Jill Leversage

Stay updated with breaking news from Director jill leversage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Down 5% After Analyst Downgrade

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP)’s stock price fell 5% during mid-day trading on Tuesday after SVB Leerink lowered their price target on the stock from $30.00 to $22.00. SVB Leerink currently has an outperform rating on the stock. Aurinia Pharmaceuticals traded as low as $9.98 and last traded at $10.14. 220,268 shares […] ....

Thomson Reuter , Jill Leversage , Selective Wealth Management Inc , Aurinia Pharmaceuticals Inc , Zacks Investment Research , Capital Group , Lazard Asset Management , Jefferies Financial Group , Aurinia Pharmaceuticals Company Profile , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals , Macquarie Group Ltd , Royal Bank , Get Rating , Financial Group , Investment Research , Director Jill Leversage , Wealth Management , Asset Management , Private Capital Group , Pharmaceuticals Company Profile , Pharmaceuticals Inc , Nasdaq Auph ,

FY2022 Earnings Estimate for Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Issued By Jefferies Financial Group

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) – Research analysts at Jefferies Financial Group boosted their FY2022 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a research report issued on Tuesday, March 1st. Jefferies Financial Group analyst M. Raycroft now forecasts that the biotechnology company will earn ($0.77) per share for […] ....

Thomson Reuter , Jill Leversage , Aurinia Pharmaceuticals Inc , Zacks Investment Research , Capital Group , Swiss National Bank , Deutsche Bank , Diamond Hill Capital Management Inc , Aurinia Pharmaceuticals Company Profile Get Rating , Jefferies Financial Group , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals , Royal Bank , Get Rating , Financial Group , Investment Research , Director Jill Leversage , Hill Capital Management , National Bank , Pharmaceuticals Company Profile , Pharmaceuticals Inc , Nasdaq Auph , Earnings Estimates , Jefferies Financial Group Inc ,

Q1 2022 Earnings Estimate for Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Issued By SVB Leerink

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) – SVB Leerink decreased their Q1 2022 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a report released on Monday, February 28th. SVB Leerink analyst J. Schwartz now anticipates that the biotechnology company will post earnings per share of ($0.24) for the quarter, down […] ....

United Kingdom , Jill Leversage , Schonfeld Strategic Advisors , Aurinia Pharmaceuticals Inc , Kestra Private Wealth Services , Zacks Investment Research , Aurinia Pharmaceuticals Company Profile Get Rating , Jefferies Financial Group , Asset Management Americas Inc , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals , Clarity Wealth Management Inc , Royal Bank , Get Rating , Director Jill Leversage , Management Americas , Clarity Wealth Management , Strategic Advisors , Pharmaceuticals Company Profile , Pharmaceuticals Inc , Nasdaq Auph , Earnings Estimates , Svb Leerink Llc ,

Aurinia Pharmaceuticals (NASDAQ:AUPH) Announces Earnings Results, Beats Expectations By $0.02 EPS

Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Rating) (TSE:AUP) posted its quarterly earnings data on Sunday. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.02, MarketWatch Earnings reports. Aurinia Pharmaceuticals had a negative return on equity of 44.22% and a negative net margin of 215.58%. During […] ....

Jill Leversage , Aurinia Pharmaceuticals Inc , Securities Exchange Commission , Deutsche Bank , Invesco Ltd , Aurinia Pharmaceuticals Company Profile Get Rating , Jefferies Financial Group , Earnings History For Aurinia Pharmaceuticals , Otsuka Pharmaceutical Co Ltd , Aurinia Pharmaceuticals , Royal Bank , Get Rating , Marketwatch Earnings , Director Jill Leversage , Exchange Commission , Asset Management Gmbh , Montreal Can , Financial Group , Pharmaceuticals Company Profile , Pharmaceuticals Inc , Nasdaq Auph ,